NasdaqCM - Nasdaq Real Time Price USD
NLS Pharmaceutics AG (NLSP)
1.4305
-0.0495
(-3.34%)
As of 10:59:34 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-9,684.4660
-9,684.4660
-13,879.3710
-14,936.0440
-729.3860
Investing Cash Flow
--
--
--
-39.5600
--
Financing Cash Flow
1,633.7460
1,633.7460
17,396.6690
20,337.8390
503.5220
End Cash Position
897.6800
897.6800
8,948.4000
5,431.2020
93.7110
Interest Paid Supplemental Data
145.1530
145.1530
13.2480
339.9320
--
Capital Expenditure
--
--
--
-39.5600
--
Issuance of Capital Stock
--
--
9,218.0550
14,550.1510
--
Issuance of Debt
1,633.7460
1,633.7460
1,530
108.6100
1,190.2230
Repayment of Debt
--
--
-704.1600
-2,213.1100
--
Free Cash Flow
-9,684.4660
-9,684.4660
-13,879.3710
-14,975.6040
-729.3860
12/31/2020 - 1/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KMSTF Kadimastem Ltd
5.06
+690.13%
KDST.TA Kadimastem Ltd
2,678.00
+0.34%
OSRH OSR Holdings, Inc.
1.3850
+1.09%
SXTP 60 Degrees Pharmaceuticals, Inc.
3.4100
+13.56%
LIXT Lixte Biotechnology Holdings, Inc.
1.2800
-2.29%
ONCO Onconetix, Inc.
0.0650
-2.55%
NRSN NeuroSense Therapeutics Ltd.
1.0100
+3.55%
GRTX Galera Therapeutics, Inc.
0.0243
+3.19%
CNTX Context Therapeutics Inc.
0.8612
-8.75%
BDRX Biodexa Pharmaceuticals Plc
1.5000
+5.63%